Li Fu

3.8k total citations
119 papers, 2.8k citations indexed

About

Li Fu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Li Fu has authored 119 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 41 papers in Cancer Research and 40 papers in Oncology. Recurrent topics in Li Fu's work include Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (19 papers) and Cancer Cells and Metastasis (16 papers). Li Fu is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (19 papers) and Cancer Cells and Metastasis (16 papers). Li Fu collaborates with scholars based in China, United States and Japan. Li Fu's co-authors include Feng Gu, Xiaojing Guo, Xinmin Zhang, Yu Fan, Ronggang Lang, Fangfang Liu, Yongjie Ma, Bo Xu, Xiaolong Qian and Yi-Ling Yang and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Li Fu

115 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Fu China 32 1.5k 963 917 442 323 119 2.8k
Margaret C. Cummings Australia 32 1.5k 1.0× 1.0k 1.0× 1.4k 1.5× 735 1.7× 233 0.7× 74 3.2k
Thomas Bogenrieder Germany 25 1.2k 0.8× 536 0.6× 1.2k 1.3× 128 0.3× 371 1.1× 63 2.6k
Junichi Kurebayashi Japan 37 1.8k 1.2× 999 1.0× 1.9k 2.1× 273 0.6× 225 0.7× 157 3.8k
Anita Mangia Italy 29 1.4k 0.9× 797 0.8× 1.2k 1.3× 243 0.5× 300 0.9× 108 2.7k
Jórunn E. Eyfjörd Iceland 30 2.0k 1.3× 1.3k 1.3× 1.4k 1.5× 600 1.4× 67 0.2× 64 3.8k
Mohamed Mokhtar Desouki United States 30 1.1k 0.7× 733 0.8× 476 0.5× 375 0.8× 214 0.7× 87 2.8k
Margit A. Huber Germany 13 2.3k 1.6× 1.2k 1.3× 1.8k 2.0× 215 0.5× 396 1.2× 21 3.7k
Somaira Nowsheen United States 37 2.1k 1.4× 480 0.5× 1.3k 1.4× 130 0.3× 341 1.1× 74 3.2k
Hisashi Hirakawa Japan 24 805 0.5× 752 0.8× 839 0.9× 216 0.5× 232 0.7× 63 2.0k
Sherry X. Yang United States 21 1.8k 1.2× 904 0.9× 1.5k 1.6× 171 0.4× 203 0.6× 54 3.2k

Countries citing papers authored by Li Fu

Since Specialization
Citations

This map shows the geographic impact of Li Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Fu more than expected).

Fields of papers citing papers by Li Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Fu. The network helps show where Li Fu may publish in the future.

Co-authorship network of co-authors of Li Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Fu. A scholar is included among the top collaborators of Li Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Fu. Li Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Juan, Yang Li, Yingru Liu, et al.. (2025). Comprehensive single-cell analysis deciphered the immunoregulatory mechanism of TPPU in alleviating sepsis-related acute liver injury. Journal of Advanced Research. 71. 457–470. 1 indexed citations
2.
Zhang, Yan, Shiyang Liu, Liying Huang, et al.. (2025). HFIP‐Promoted E ‐selective Asymmetric Crotylboration of Quaternary α‐Silyl Crotylboronate with Aldehydes. Angewandte Chemie International Edition. 64(30). e202508944–e202508944. 2 indexed citations
4.
Zhao, Huanyu, Ying Wen, Jun Sun, et al.. (2024). Perturbation of mammary epithelial cell apicobasal polarity by RHBDF1-facilitated nuclear translocation of PKCζ. Biological Research. 57(1). 90–90. 1 indexed citations
5.
Lou, Ning, Xinyu Gu, Li Fu, Juan Li, & Chen Xue. (2024). Significant roles of RNA 5-methylcytosine methylation in cancer. Cellular Signalling. 126. 111529–111529. 4 indexed citations
6.
Nie, Xin, Li Fu, Yanfen Cheng, et al.. (2023). Garcinone E suppresses breast cancer growth and metastasis by modulating tumor‐associated macrophages polarization via STAT6 signaling. Phytotherapy Research. 37(10). 4442–4456. 17 indexed citations
7.
Luo, Lin, Zhiqi Chen, Chen Xue, et al.. (2023). Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals. 16(4). 548–548. 5 indexed citations
8.
Tian, Yao, Jing Hu, Huan Zhang, et al.. (2021). Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer. Frontiers in Oncology. 11. 703501–703501. 7 indexed citations
9.
Li, Weidong, Yunwei Han, Xiaojing Guo, et al.. (2018). Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study. Modern Pathology. 31(6). 956–964. 29 indexed citations
10.
Zhou, Zhuan, et al.. (2014). Human Rhomboid Family-1 Suppresses Oxygen-Independent Degradation of Hypoxia-Inducible Factor-1α in Breast Cancer. Cancer Research. 74(10). 2719–2730. 38 indexed citations
11.
Kasai, Tomonari, et al.. (2014). Cancer Stem Cells Converted from Pluripotent Stem Cells and the Cancerous Niche. SHILAP Revista de lepidopterología. 10(1). 2–7. 19 indexed citations
12.
Ding, Ting, Minghao Yin, Kai Sun, et al.. (2013). Knockdown a Water Channel Protein, Aquaporin-4, Induced Glioblastoma Cell Apoptosis. PLoS ONE. 8(8). e66751–e66751. 39 indexed citations
13.
Yang, Cuicui, Fangfang Liu, Yiling Yang, et al.. (2012). Accessory Breast Cancer Occurring Concurrently with Bilateral Primary Invasive Breast Carcinomas: A Report of Two Cases and Literature Review. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Yang, Yi-Ling, et al.. (2012). Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance. Breast Cancer Research and Treatment. 134(3). 1095–1102. 34 indexed citations
15.
Yang, Cuicui, Fangfang Liu, Shuai Li, et al.. (2012). Lymph Node Ratio. International Journal of Surgical Pathology. 20(6). 546–554. 7 indexed citations
16.
Zhao, Yue, Li Fu, Rong Li, et al.. (2012). Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Medicine. 10(1). 153–153. 182 indexed citations
17.
Li, Yaqing, Qi Tong, Feng Gu, et al.. (2012). δEF1 Down-Regulates ER-α Expression and Confers Tamoxifen Resistance in Breast Cancer. PLoS ONE. 7(12). e52380–e52380. 18 indexed citations
18.
Sun, Mianen, Xiaojing Guo, Xiaolong Qian, et al.. (2012). Activation of the ATM-Snail pathway promotes breast cancer metastasis. Journal of Molecular Cell Biology. 4(5). 304–315. 94 indexed citations
19.
Yang, Chunying, Xi Tang, Xiaojing Guo, et al.. (2011). Aurora-B Mediated ATM Serine 1403 Phosphorylation Is Required for Mitotic ATM Activation and the Spindle Checkpoint. Molecular Cell. 44(4). 597–608. 93 indexed citations
20.
Chen, Xiaohong, et al.. (2001). Pathological study of resected specimens of hepatocellular carcinoma after different ways of interventional treatment. Zhonghua fangshexian yixue zazhi. 35(12). 903–907.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026